The presented study aims at analyzing an increasing prevalence of vancomycin-resistant enterococci (VRE) isolated from various kinds of clinical material obtained from patients in the Department of Hemato-oncology (DHO), University Hospital in Olomouc, Czech Republic.
INTRODUCTION
Recently, the importance of gram-positive, often multiresistant, bacteria in the etiopathogenesis of -particularly nosocomial -infectious has increased. Among these, a significant role is played by vancomycin-resistant enterococci (VRE) present especially in patients with hematooncological diseases and those in intensive care units 1 . Although they mostly represent mere colonization of the gastrointestinal tract they can also cause serious infections which are difficult to manage therapeutically.
VRE were first isolated in Europe in 1986 and a year later in the USA 2, 3, 4 . At present, VRE are described in other countries in the world. In the Czech Republic, VRE were first reported at the Department of Hematooncology, University Hospital Olomouc (DHO) in 1997 5 . The presented study aims at analysing an increased prevalence of VRE in the DHO patients in early 2005, assessing their importance and formulating a hypothesis concerning their source and potential transmission pathways as based on a molecular biology analysis of VanA Enterococcus faecium strains.
MATERIAL AND METHODS
By using standard microbiological procedures, enterococci were isolated from clinical material (sputum and upper respiratory tract swabs, pus, blood, samples from cannula and catheter surfaces, urine and rectal swabs) obtained from patients hospitalized in the DHO between January 1 and March 31, 2005. Enterococcal strains were identified according to the criteria of Facklam and Collins and biochemical properties using the EN-COCCUStest (Pliva-Lachema) 6 . At the same time, enterococci were isolated from the above mentioned department environment. Samples were taken with a moistened cotton pad from a 100×100 mm area in two directions at right angles to each other. The samples were immediately inoculated into 5 ml Nutrient Broth w/1% peptone and 48 h cultivation at 37 °C was initiated. Following that, the liquid medium was inoculated with a calibrated loop on a solid medium (Columbia Blood Agar Base with 7 % sheep blood) and incubated under aerobic conditions at 37 °C for 48 h.
Resistance to vancomycin and teicoplanin was determined by a standardized microdilution method 7 . The limit concentrations for susceptible strains were set at 4 mg/L for vancomycin and 8 mg/L for teicoplanin. The dilution accuracy of both antibiotics was verified with Staphylococcus aureus ATCC 29213 and Enterococcus faecalis ATCC 29212 reference strains. Phenotype assessment of resistance to vancomycin was verified by PCR detection of vanA and vanB genes 8 .
In a particular patient, one strain of a given VRE species isolated from each type of clinical material as the first one was added to the database.
All VanA E. faecium strains were assessed by macrorestriction analysis using pulsed-field gel electrophoresis (PFGE). To determine strain relationship genome DNA fragments were compared which had been cleaved by SmaI restriction endonuclease (Roche Diagnostics) and separated by PFGE (CHEF Mapper, Bio-Rad). The PFGE profiles of individual isolates were evaluated according to the criteria described by Goering 9 . The results were statistically processed by a cluster analysis (Gel Compar, Applied Maths) as used by Kolar et al. for molecular biology analysis of VRE of animal origin 10 .
RESULTS
During the observed period, a total of 128 Enterococcus sp. strains were isolated from biological material obtained from the DHO patients. Of those, 38 (30 %) isolates from 22 different patients were determined as VRE. Their species, phenotypes and genotypes are listed in Table  1 . Dominant were VanA E. faecium (63 %) and VanC E. casseliflavus (16 %) strains. At the same time, one VanA Enterococcus faecium strain was acquired from the department environment, namely a bed-side table used by a patient in whom a similar strain had been isolated repeatedly from various clinical materials (oral cavity, urine, stools, and even stools analyzed in 2004). Table 2 gives an overview of VRE in individual types of clinical material. Most frequently, VRE were isolated from rectal swabs (76 %), less frequently from urine (21 %) and only in 3 % from the upper respiratory tract swabs. No VRE strain was detected in blood.
In the case of 5 (23 %) patients, VRE were isolated not only from stools but also from urine. One patient had VRE in stools, urine and the upper respiratory tract swab, all at once. Of particular interest is that in 5 patients 2 VRE species were detected (E. faecium + Enterococcus faecalis, E. faecium + E. casseliflavus, E. faecium + E. sp.) and in one patient even 3 species (E. faecium, E. faecalis, E. sp.). The most common isolate, VanA E. faecium (24 strains from 17 patients), was cultivated solely from stools in 11 (64 %) patients, both from stools and urine in 5 patients (30 %) and from stools, urine and the upper respiratory tract swab in one patient. Epidemiologically important is the fact that during the week of February Eleven strains were from stools, 2 from urine, 1 from the oral cavity and 1 from the environment -a surface of a bed-side table used by a patient with isolated VanA E. faecium. In one patient, the isolation was simultaneous from both stools and urine, in another patient from urine, the oral cavity and the bed-side table surface. Five strains isolated between January 12 and March 29, 2005 with concordance from 90 % to 100 % could be classified as type B. These were 2 strains from stools and 3 strains from urine, in one patient the same strains were isolated simultaneously from both stools and urine. The C clonal type comprised 4 strains with 99 % concordance -3 strains were from the patients' stools from the period of January 11 to March 10, 2005, and one strain was from the 2004 stools test in a patient in whom three other VRE of the clonal type A were isolated (from urine, the oral cavity and the bed-side table surface). The remaining two strains were of a unique restriction profile and could not be assigned to any of the above mentioned clonal types. The PFGE results showing relationship of all the 26 analyzed strains are in Fig. 1 .
DISCUSSION
The presence of VRE poses a potential risk especially for hemato-oncological, oncological and other patients with significant immunosuppression. Most cases are those with mere colonization of the gastrointestinal tract. However, VRE strains may act as etiological agents of serious urinary and respiratory infections and generalized sepses 11 .
From an epidemiological point of view, the most dangerous are VanA and VanB phenotypes of VRE as they represent resistance which is acquired and transferable 12, ˝é13 . Since 1997, VRE have been regularly isolated from clinical material obtained from the DHO patients and their frequency rate among all enterococcal isolates reaches 5 % on average 5, 14 .
Due to the increased prevalence of VRE in the first three months of 2005 (30 %) a macrorestriction analysis of genome DNA of VanA E. faecium strains isolated from clinical material obtained from the DHO patients and one strain isolated from the department environment was carried out. The results suggest both endogenous and exogenous sources of the strains. The endogenous origin can be proved by detection of 8 unique restriction profiles. It can be assumed that on their admission to the hospital some patients are already colonized with VRE The results of the presented study clearly confirm both an endogenous origin of VRE and their potential capability of clonal and horizontal spread in a hospital environment. It is obvious that, apart from the rational use of antimicrobial agents, the prevention of the spread of bacterial resistance, including VRE, can only be achieved by applying strict hygienic and epidemiological measures.
